Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

McEachern

Showing results (481-490 of 494) with videos related to

Pageof 50
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 5, 2019
Expression Analysis and Significance of PD-1, LAG-3, and TIM-3 in Human Non-Small Cell Lung Cancer Using Spatially Resolved and Multiparametric Single-Cell AnalysisIla Datar, Miguel F Sanmamed, Jun Wang, et al.
Nature Medicine|April 8, 2017
Erratum: PIM1 kinase regulates cell death, tumor growth and chemotherapy response in triple-negative breast cancerFara Brasó-Maristany, Simone Filosto, Steven Catchpole, et al.
Nature Medicine|November 8, 2016
PIM1 kinase regulates cell death, tumor growth and chemotherapy response in triple-negative breast cancerFara Brasó-Maristany, Simone Filosto, Steven Catchpole, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|October 9, 2018
Copy-number variants in clinical genome sequencing: deployment and interpretation for rare and undiagnosed diseaseAndrew M Gross, Subramanian S Ajay, Vani Rajan, et al.
Molecular Neurodegeneration|May 20, 2017
Inhibition of O-GlcNAcase leads to elevation of O-GlcNAc tau and reduction of tauopathy and cerebrospinal fluid tau in rTg4510 miceNicholas B Hastings, Xiaohai Wang, Lixin Song, et al.
Nature Medicine|June 7, 2017
Erratum: PIM1 kinase regulates cell death, tumor growth and chemotherapy response in triple-negative breast cancerFara Brasó-Maristany, Simone Filosto, Steven Catchpole, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 5, 2020
MK-8719, a Novel and Selective <i>O</i>-GlcNAcase Inhibitor That Reduces the Formation of Pathological Tau and Ameliorates Neurodegeneration in a Mouse Model of TauopathyXiaohai Wang, Wenping Li, Jacob Marcus, et al.
Journal of Medicinal Chemistry|October 5, 2013
Design of substituted imidazolidinylpiperidinylbenzoic acids as chemokine receptor 5 antagonists: potent inhibitors of R5 HIV-1 replicationRenato Skerlj, Gary Bridger, Yuanxi Zhou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 1, 2022
Lisaftoclax (APG-2575) Is a Novel BCL-2 Inhibitor with Robust Antitumor Activity in Preclinical Models of Hematologic MalignancyJing Deng, Aneel Paulus, Douglas D Fang, et al.
JAMA|April 30, 2026
Management of Chronic Subdural Hematoma With Adjunctive Embolization of Middle Meningeal Artery: The EMMA-Can Randomized Clinical TrialJai Jai Shiva Shankar, Susan Alcock, Nima Kashani, et al.
Pageof 50

Showing results (481-490 of 494) with videos related to

Sort By:
Pageof 50
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 5, 2019
Expression Analysis and Significance of PD-1, LAG-3, and TIM-3 in Human Non-Small Cell Lung Cancer Using Spatially Resolved and Multiparametric Single-Cell AnalysisIla Datar, Miguel F Sanmamed, Jun Wang, et al.
Nature Medicine|April 8, 2017
Erratum: PIM1 kinase regulates cell death, tumor growth and chemotherapy response in triple-negative breast cancerFara Brasó-Maristany, Simone Filosto, Steven Catchpole, et al.
Nature Medicine|November 8, 2016
PIM1 kinase regulates cell death, tumor growth and chemotherapy response in triple-negative breast cancerFara Brasó-Maristany, Simone Filosto, Steven Catchpole, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|October 9, 2018
Copy-number variants in clinical genome sequencing: deployment and interpretation for rare and undiagnosed diseaseAndrew M Gross, Subramanian S Ajay, Vani Rajan, et al.
Molecular Neurodegeneration|May 20, 2017
Inhibition of O-GlcNAcase leads to elevation of O-GlcNAc tau and reduction of tauopathy and cerebrospinal fluid tau in rTg4510 miceNicholas B Hastings, Xiaohai Wang, Lixin Song, et al.
Nature Medicine|June 7, 2017
Erratum: PIM1 kinase regulates cell death, tumor growth and chemotherapy response in triple-negative breast cancerFara Brasó-Maristany, Simone Filosto, Steven Catchpole, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 5, 2020
MK-8719, a Novel and Selective <i>O</i>-GlcNAcase Inhibitor That Reduces the Formation of Pathological Tau and Ameliorates Neurodegeneration in a Mouse Model of TauopathyXiaohai Wang, Wenping Li, Jacob Marcus, et al.
Journal of Medicinal Chemistry|October 5, 2013
Design of substituted imidazolidinylpiperidinylbenzoic acids as chemokine receptor 5 antagonists: potent inhibitors of R5 HIV-1 replicationRenato Skerlj, Gary Bridger, Yuanxi Zhou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 1, 2022
Lisaftoclax (APG-2575) Is a Novel BCL-2 Inhibitor with Robust Antitumor Activity in Preclinical Models of Hematologic MalignancyJing Deng, Aneel Paulus, Douglas D Fang, et al.
JAMA|April 30, 2026
Management of Chronic Subdural Hematoma With Adjunctive Embolization of Middle Meningeal Artery: The EMMA-Can Randomized Clinical TrialJai Jai Shiva Shankar, Susan Alcock, Nima Kashani, et al.
Pageof 50